129 related articles for article (PubMed ID: 7089337)
21. Severe renal failure in multiple myeloma.
Cosio FG; Pence TV; Shapiro FL; Kjellstrand CM
Proc Clin Dial Transplant Forum; 1980; 10():177-80. PubMed ID: 6810342
[No Abstract] [Full Text] [Related]
22. [Myeloma and renal insufficiency].
Schifferli JA
Schweiz Rundsch Med Prax; 1986 Nov; 75(45):1343-4. PubMed ID: 3787018
[No Abstract] [Full Text] [Related]
23. Renal failure and multiple myeloma.
Weininger RB; Luikart S; Bia M; Kashgarian M
Ann Intern Med; 1980 Oct; 93(4):644. PubMed ID: 7436210
[No Abstract] [Full Text] [Related]
24. [Letter: Renal insufficiency in multiple myeloma and its treatment by periodic hemodialysis].
Wiederkehr JL; Marichal JF; Triby F
Nouv Presse Med; 1976 Jul 3-10; 5(27):1698. PubMed ID: 958876
[No Abstract] [Full Text] [Related]
25. [Multiple myeloma. Clinical review of 56 cases].
López Alvarez J; Sanz Marca A; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):175-8. PubMed ID: 6669751
[No Abstract] [Full Text] [Related]
26. [Kidney and urinary tract complications in tumor patients].
Joss R; Goldhirsch A; Brunner K
Schweiz Med Wochenschr; 1980 Mar; 110(11):390-404. PubMed ID: 6988956
[TBL] [Abstract][Full Text] [Related]
27. Multiple complications in multiple myeloma.
Basi S; Schulman G; Fogo AB
Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
[No Abstract] [Full Text] [Related]
28. [Multiple myeloma: description of a series of 170 cases].
Bladé J; Rozman C; Montserrat E; Grañena A; Brugués R; Cervantes F; Feliu E; Marín P; Nomdedeu B; Vives-Corrons JL
Med Clin (Barc); 1984 Feb; 82(7):287-94. PubMed ID: 6717133
[No Abstract] [Full Text] [Related]
29. [Treatment of renal insufficiency in patients with multiple myeloma].
Vulić D; Radlović O; Stanojcić A; Radmilović A; Rajić M
Srp Arh Celok Lek; 1996; 124 Suppl 1():53-5. PubMed ID: 9102930
[TBL] [Abstract][Full Text] [Related]
30. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
[TBL] [Abstract][Full Text] [Related]
31. [Renal failure in Kahler's disease].
Olmer M; Lafon J
Presse Med (1893); 1969 Jan; 77(2):41-2. PubMed ID: 5785069
[No Abstract] [Full Text] [Related]
32. [Multiple myeloma and retroperitoneal fibrosis].
Beccari G
Minerva Med; 1989 Jan; 80(1):79-80. PubMed ID: 2915817
[No Abstract] [Full Text] [Related]
33. [Analysis of renal changes and factors causing renal failure in patients with multiple myeloma].
Kraj M; Mendek E; Letowska M; Rostkowska J; Maj S; Pawlikowski J
Acta Haematol Pol; 1983; 14(2):77-87. PubMed ID: 6673470
[No Abstract] [Full Text] [Related]
34. Multiple myeloma treatment in dialysis-dependent patients: to transplant or not to transplant?
van Bommel EF
Nephrol Dial Transplant; 1996 Jul; 11(7):1486-7. PubMed ID: 8815425
[No Abstract] [Full Text] [Related]
35. The kidney in multiple myeloma.
West J Med; 1978 Jul; 129(1):41-8. PubMed ID: 685267
[No Abstract] [Full Text] [Related]
36. Some characteristics of renal injury in plasma cell dyscrasias.
Drazen F; Lenert P; Tepavcević P; Ilić V; Curić S; Uzurov V; Pejin D; Zupunski A; Vodopivec S; Djisalov M
Przegl Lek; 1985; 42(4):372-4. PubMed ID: 4048521
[No Abstract] [Full Text] [Related]
37. Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.
Carlson K; Hjorth M; Knudsen LM;
Br J Haematol; 2005 Mar; 128(5):631-5. PubMed ID: 15725084
[TBL] [Abstract][Full Text] [Related]
38. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
[TBL] [Abstract][Full Text] [Related]
39. Approach to acute renal failure with multiple myeloma: role of plasmapheresis.
El-Achkar TM; Sharfuddin AA; Dominguez J
Ther Apher Dial; 2005 Oct; 9(5):417-22. PubMed ID: 16202018
[TBL] [Abstract][Full Text] [Related]
40. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
Chim CS
Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
